DIA
WST icon

Denver Investment Advisors’s West Pharmaceutical WST Stock Holding History

Denver Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-233,929
Closed -$17.8M – 474
2016
Q2 		$17.8M Sell
233,929
-114,889
-33% -$8.36M 0.8% 29
2016
Q1 		$24.2M Buy
348,818
+2,238
+0.6% +$135K 1.07% 8
2015
Q4 		$20.9M Sell
346,580
-28,440
-8% -$1.71M 0.94% 16
2015
Q3 		$20.3M Sell
375,020
-176,983
-32% -$10.3M 0.88% 27
2015
Q2 		$32.1M Sell
552,003
-8,824
-2% -$493K 1.19% 8
2015
Q1 		$33.8M Sell
560,827
-319,859
-36% -$17M 1.11% 9
2014
Q4 		$46.9M Sell
880,686
-67,579
-7% -$3.38M 1.5% 3
2014
Q3 		$42.4M Buy
948,265
+7,356
+0.8% +$313K 1.39% 5
2014
Q2 		$39.7M Buy
940,909
+189,836
+25% +$8.13M 1.21% 9
2014
Q1 		$33.1M Sell
751,073
-385,276
-34% -$18.1M 0.97% 13
2013
Q4 		$55.7M Sell
1,136,349
-44,988
-4% -$2.11M 1.58% 2
2013
Q3 		$48.6M Sell
1,181,337
-397,999
-25% -$15.2M 1.03% 17
2013
Q2 		$55.5M Buy
+1,579,336
New +$52M 1.27% 6

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Denver Investment Advisors's WST Position: Q3 2016 in Review

Denver Investment Advisors sold out of West Pharmaceutical (WST) in Q3 2016, closing a stake of 233,929 shares — an estimated $17.8M sold.

Denver Investment Advisors first reported a position in WST in Q2 2013 and held it in 13 quarters. The position peaked at $55.7M in Q4 2013. 280 funds tracked by Wall St. Rank hold WST as of Q3 2016.

  • Denver Investment Advisors reported no remaining West Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 233,929 West Pharmaceutical shares in Q3 2016, an estimated $17.8M.
  • Denver Investment Advisors first reported a position in West Pharmaceutical in Q2 2013 and held it in 13 quarters.
  • Denver Investment Advisors's West Pharmaceutical position peaked at $55.7M in Q4 2013.
  • 280 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on Denver Investment Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.